These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 16269145

  • 1. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
    Lee WY, Lee EA, Jeon MY, Kang HY, Park YG.
    Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
    [Abstract] [Full Text] [Related]

  • 2. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.
    Lee WY, Chang JW, Nemeth NL, Kang UJ.
    J Neurosci; 1999 Apr 15; 19(8):3266-74. PubMed ID: 10191339
    [Abstract] [Full Text] [Related]

  • 3. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
    Doroudchi MM, Liauw J, Heaton K, Zhen Z, Forsayeth JR.
    J Neurochem; 2005 May 15; 93(3):634-40. PubMed ID: 15836622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.
    Exp Neurol; 2004 Jul 15; 188(1):65-73. PubMed ID: 15191803
    [Abstract] [Full Text] [Related]

  • 6. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.
    Brain Res Rev; 2006 Sep 15; 52(2):244-56. PubMed ID: 16644019
    [Abstract] [Full Text] [Related]

  • 7. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
    Su Y, Duan CL, Zhao CL, Zhao HY, Xu QY, Yang H.
    Sheng Li Xue Bao; 2003 Oct 25; 55(5):583-8. PubMed ID: 14566408
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gene therapy for Parkinson's disease: determining the genes necessary for optimal dopamine replacement in rat models.
    Kang UJ, Lee WY, Chang JW.
    Hum Cell; 2001 Mar 25; 14(1):39-48. PubMed ID: 11436352
    [Abstract] [Full Text] [Related]

  • 10. Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats.
    Sanftner LM, Rivera VM, Suzuki BM, Feng L, Berk L, Zhou S, Forsayeth JR, Clackson T, Cunningham J.
    Mol Ther; 2006 Jan 25; 13(1):167-74. PubMed ID: 16126007
    [Abstract] [Full Text] [Related]

  • 11. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS, Fisher A, Starr MS.
    Synapse; 1998 Nov 25; 30(3):309-17. PubMed ID: 9776134
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Production of Dopamine by Aromatic l-Amino Acid Decarboxylase Cells after Spinal Cord Injury.
    Ren LQ, Wienecke J, Hultborn H, Zhang M.
    J Neurotrauma; 2016 Jun 15; 33(12):1150-60. PubMed ID: 26830512
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V, Sosti V, Rubio A, Barbanoj M, Rodríguez-Alvarez J, Kulisevsky J.
    Eur J Pharmacol; 2007 Dec 08; 576(1-3):83-90. PubMed ID: 17888901
    [Abstract] [Full Text] [Related]

  • 18. In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase.
    Leff SE, Rendahl KG, Spratt SK, Kang UJ, Mandel RJ.
    Exp Neurol; 1998 Jun 08; 151(2):249-64. PubMed ID: 9628761
    [Abstract] [Full Text] [Related]

  • 19. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA, Mattern C, Häcker R, Tomaz C, Huston JP, Schwarting RK.
    Synapse; 1997 Dec 08; 27(4):294-302. PubMed ID: 9372552
    [Abstract] [Full Text] [Related]

  • 20. The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations.
    Lee EA, Lee WY, Kim YS, Kang UJ.
    Exp Neurol; 2003 Nov 08; 184(1):304-12. PubMed ID: 14637101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.